Biopharmaceutical Analysis & Statistics, March 2015 (p6)

24/7 Customer Support

Talk to Louis

+1 718 618 4302

Publishers

All regions

151-180 of about 1 900 reports

Purchase Reports From Reputable Market Research Publishers

Alexion Pharmaceuticals, Inc. - Product Pipeline Review - 2015

Alexion Pharmaceuticals, Inc. - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • March 2015
  • by Global Markets Direct

Alexion Pharmaceuticals, Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Alexion Pharmaceuticals, Inc. - Product Pipeline Review - 2015’, provides an overview of the Alexion ...

  • Industries : Pharmaceutical
  • Countries : United States
Altor BioScience Corporation - Product Pipeline Review - 2015

Altor BioScience Corporation - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • March 2015
  • by Global Markets Direct

Altor BioScience Corporation - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Altor BioScience Corporation - Product Pipeline Review - 2015’, provides an overview of the Alto ...

  • Industries : Pathology
  • Countries : United States
USV Limited - Product Pipeline Review - 2015

USV Limited - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • March 2015
  • by Global Markets Direct

USV Limited - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘USV Limited - Product Pipeline Review - 2015’, provides an overview of the USV Limited’s pharmaceutical research and ...

  • Industries : Research and Development, Drug and Medication, Biopharmaceutical
  • Countries : India, World
Orphazyme ApS - Product Pipeline Review - 2015

Orphazyme ApS - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • March 2015
  • by Global Markets Direct

Orphazyme ApS - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Orphazyme ApS - Product Pipeline Review - 2015’, provides an overview of the Orphazyme ApS’s pharmaceutical research ...

  • Industries : Research and Development, Pathology
  • Countries : World, Europe
Shanghai Zerun Biotechnology Co., Ltd. - Product Pipeline Review - 2015

Shanghai Zerun Biotechnology Co., Ltd. - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • February 2015
  • by Global Markets Direct

Shanghai Zerun Biotechnology Co., Ltd. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Shanghai Zerun Biotechnology Co., Ltd. - Product Pipeline Review - 2015’, provides an overview ...

  • Industries : Biotechnology, Biopharmaceutical, Drug and Medication, Research and Development
  • Countries : China, World
FIT Biotech Oy - Product Pipeline Review - 2015

FIT Biotech Oy - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • February 2015
  • by Global Markets Direct

FIT Biotech Oy - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘FIT Biotech Oy - Product Pipeline Review - 2015’, provides an overview of the FIT Biotech Oy’s pharmaceutical research ...

  • Industries : Biotechnology, Biopharmaceutical, Drug and Medication
  • Countries : World
EpiVax, Inc. - Product Pipeline Review - 2015

EpiVax, Inc. - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • February 2015
  • by Global Markets Direct

EpiVax, Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘EpiVax, Inc. - Product Pipeline Review - 2015’, provides an overview of the EpiVax, Inc.’s pharmaceutical research ...

  • Industries : Biopharmaceutical, Research and Development, Drug and Medication
  • Countries : United States
Alnylam Pharmaceuticals, Inc. - Product Pipeline Review - 2015

Alnylam Pharmaceuticals, Inc. - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • February 2015
  • by Global Markets Direct

Alnylam Pharmaceuticals, Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Alnylam Pharmaceuticals, Inc. - Product Pipeline Review - 2015’, provides an overview of the Alnylam ...

  • Industries : Pharmaceutical, Research and Development
  • Countries : United States
ActogeniX NV - Product Pipeline Review - 2015

ActogeniX NV - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • February 2015
  • by Global Markets Direct

ActogeniX NV - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘ActogeniX NV - Product Pipeline Review - 2015’, provides an overview of the ActogeniX NV’s pharmaceutical research ...

  • Industries : Research and Development, Pathology, Biopharmaceutical
  • Countries : United States, World
Genentech, Inc. - Product Pipeline Review - 2015

Genentech, Inc. - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • February 2015
  • by Global Markets Direct

Genentech, Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Genentech, Inc. - Product Pipeline Review - 2015’, provides an overview of the Genentech, Inc.’s pharmaceutical ...

  • Industries : Pathology, Research and Development, General Medicine and Specialty Medicine
  • Countries : United States
F. Hoffmann-La Roche Ltd. - Product Pipeline Review - 2015

F. Hoffmann-La Roche Ltd. - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • February 2015
  • by Global Markets Direct

F. Hoffmann-La Roche Ltd. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘F. Hoffmann-La Roche Ltd. - Product Pipeline Review - 2015’, provides an overview of the F. Hoffmann-La ...

  • Industries : Pathology
  • Countries : United States
GlycoVaxyn AG - Product Pipeline Review - 2015

GlycoVaxyn AG - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • February 2015
  • by Global Markets Direct

GlycoVaxyn AG - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘GlycoVaxyn AG - Product Pipeline Review - 2015’, provides an overview of the GlycoVaxyn AG’s pharmaceutical research ...

  • Industries : Biopharmaceutical
  • Countries : World
MorphoSys AG - Product Pipeline Review - 2015

MorphoSys AG - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • February 2015
  • by Global Markets Direct

MorphoSys AG - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘MorphoSys AG - Product Pipeline Review - 2015’, provides an overview of the MorphoSys AG’s pharmaceutical research ...

  • Industries : Biopharmaceutical, Pathology, Research and Development, In Vitro Diagnostic, In Vitro Diagnostic
  • Countries : World
Crucell N.V. - Product Pipeline Review - 2015

Crucell N.V. - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • February 2015
  • by Global Markets Direct

Crucell N.V. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Crucell N.V. - Product Pipeline Review - 2015’, provides an overview of the Crucell N.V.’s pharmaceutical research ...

  • Industries : Biopharmaceutical, Research and Development, Drug and Medication
  • Countries : United States
Advaxis, Inc. - Product Pipeline Review - 2015

Advaxis, Inc. - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • February 2015
  • by Global Markets Direct

Advaxis, Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Advaxis, Inc. - Product Pipeline Review - 2015’, provides an overview of the Advaxis, Inc.’s pharmaceutical research ...

  • Industries : Biopharmaceutical, General Medicine and Specialty Medicine, Pathology, Biotechnology
  • Countries : United States
Immunomic Therapeutics, Inc. - Product Pipeline Review - 2015

Immunomic Therapeutics, Inc. - Product Pipeline Review - 2015

  • $ 1 500
  • Company report
  • February 2015
  • by Global Markets Direct

Immunomic Therapeutics, Inc. - Product Pipeline Review - 2015 Summary Global Markets Direct’s, ‘Immunomic Therapeutics, Inc. - Product Pipeline Review - 2015’, provides an overview of the Immunomic ...

  • Industries : Biopharmaceutical, Therapy, Pharmaceutical, Biotechnology
  • Countries : World
Global - Adult Vaccines Market & Company Analysis to 2020

Global - Adult Vaccines Market & Company Analysis to 2020

  • $ 1 490
  • Industry report
  • May 2015
  • by Igate Research

Adults are as likely as children to die from diseases that they can be immunized. For example, vaccination can prevent about 50% of deaths from pneumococcal disease and 80% of deaths from influenza-related ...

  • Industries : Biopharmaceutical, Drug and Medication
  • Countries : World
Anti-CD30 Antibody -Pipeline Insights, 2015

Anti-CD30 Antibody -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Anti-CD30 Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti-CD30 Antibody. The main objective of this report to track competito ...

  • Industries : Biopharmaceutical
Anti GM-CSF Antibody -Pipeline Insights, 2015

Anti GM-CSF Antibody -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Anti GM-CSF Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti GM-CSF Antibody. The main objective of this report to track ...

  • Industries : Biopharmaceutical, Biotechnology, Biological Therapy
Anti-CD19 Antibody -Pipeline Insights, 2015

Anti-CD19 Antibody -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Anti-CD19 Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti-CD19 Antibody. The main objective of this report to track competito ...

  • Industries : Biopharmaceutical
Factor VIII Inhibitors -Pipeline Insights, 2015

Factor VIII Inhibitors -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Factor VIII Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Factor VIII Inhibitors. The main objective of this report to ...

  • Industries : Biopharmaceutical
Tumor Necrosis Factor Receptor (TNFR) Antagonists -Pipeline Insights, 2015

Tumor Necrosis Factor Receptor (TNFR) Antagonists -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Tumor Necrosis Factor Receptor (TNFR) Antagonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Tumor Necrosis Factor Receptor (TNFR) ...

  • Industries : Biopharmaceutical
Angiotensin Converting Enzyme (ACE) Inhibitors -Pipeline Insights, 2015

Angiotensin Converting Enzyme (ACE) Inhibitors -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Angiotensin Converting Enzyme (ACE) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Angiotensin Converting Enzyme (ACE) Inhibitors. ...

  • Industries : Biopharmaceutical
Anti-CD52 Antibody -Pipeline Insights, 2015

Anti-CD52 Antibody -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Anti-CD52 Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti-CD52 Antibody. The main objective of this report to track competito ...

  • Industries : Biopharmaceutical
Insulin Like Growth Factor 1 (IGF-1) Activators -Pipeline Insights, 2015

Insulin Like Growth Factor 1 (IGF-1) Activators -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Insulin Like Growth Factor 1 (IGF-1) Activators- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Insulin Like Growth Factor 1 (IGF-1) ...

  • Industries : Biopharmaceutical
Insulin Like Growth Factor (IGF) Inhibitors -Pipeline Insights, 2015

Insulin Like Growth Factor (IGF) Inhibitors -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Insulin Like Growth Factor (IGF) Inhibitors- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Insulin Like Growth Factor (IGF) Inhibitors. ...

  • Industries : Biopharmaceutical
Glucagon Receptor Agonists -Pipeline Insights, 2015

Glucagon Receptor Agonists -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Glucagon Receptor Agonists- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Glucagon Receptor Agonists. The main objective of this report ...

  • Industries : Biopharmaceutical
Anti-CD37 Antibody -Pipeline Insights, 2015

Anti-CD37 Antibody -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Anti-CD37 Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti-CD37 Antibody. The main objective of this report to track competito ...

  • Industries : Biopharmaceutical
Anti-CD70 Antibody -Pipeline Insights, 2015

Anti-CD70 Antibody -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Anti-CD70 Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti-CD70 Antibody. The main objective of this report to track competito ...

  • Industries : Biopharmaceutical
Anti-Mucin 1 (MUC1) Antibody -Pipeline Insights, 2015

Anti-Mucin 1 (MUC1) Antibody -Pipeline Insights, 2015

  • $ 1 250
  • Industry report
  • May 2015
  • by Delve Insight

Summary DelveInsight’s, Anti-Mucin 1 (MUC1) Antibody- Pipeline Insights, 2015, provides the in-depth analysis of the pipeline assets across the Anti-Mucin 1 (MUC1) Antibody. The main objective of this ...

  • Industries : Biopharmaceutical

ReportLinker is an award-winning market research solution that finds, filters and organizes the latest industry data so you get all the market research you need - quickly, in one place.